Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response.

Publication Type:

Journal Article


AIDS (London, England), Volume 22, Issue 8, p.937-45 (2008)


2008, Adult, Anti-HIV Agents, Antineoplastic Agents, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Epidemiologic Methods, HIV Infections, HIV-1, Humans, Male, Public Health Sciences Division, Sarcoma, Kaposi, Treatment Outcome, Vaccine and Infectious Disease Institute, Viral Load


To evaluate the role of highly active antiretroviral therapy and chemotherapy on tumor response among persons with AIDS-related Kaposi sarcoma and identify factors associated with response in a clinic setting.